Study led by Psaila Group uncovers previously unknown function of platelets as DNA \u2018vacuum cleaners\u2019 in the blood, with profound implications for cancer diagnosis and prenatal screening.
Claus Nerlov, Professor of Stem Cell Biology, has been awarded funding from Wellcome to map the gene regulatory networks in blood cell production and seek new therapeutic targets.
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
Researchers at the MRC Weatherall Institute of Molecular Medicine and the German Cancer Research Center (DKFZ) have developed a new method to analyse how our tissues evolve as we age.
The MRC WIMM community gathered for its flagship annual event, WIMM Day, on Tuesday 24th June. Held at the Sa\u00efd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engagement and more.
Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.
Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.
Facility Manager Michalina Mazurczyk, based in the MRC Weatherall Institute of Molecular Medicine, has been appointed as Technician Champion for the second year.
An international collaboration, initiated by the Jackson Group at the MRC WIMM, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
A collaboration between the Drakesmith and Higgs Groups at the MRC WIMM has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.
Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.
![\"Microsopy](\"https://www.imm.ox.ac.uk/news/platelets-sequester-cfDNA-Science-2025/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n